Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

14.41 -0.55 (-3.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Twist Bioscience Corp

< Previous 1 2 3 4 5 6 Next >
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Portfolio of RNA Sequencing Tools
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at ITF World 2023
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
From Twist Bioscience Corporation
Via Business Wire
DNA Data Storage Alliance Announces Board Appointments
From DNA Data Storage Alliance
Via Business Wire
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
NASDAQ:TWST Long Term Investor Alert: Investigation of Potential Wrongdoing at Twist Bioscience Corporation
San Diego, CA -- (SBWIRE) -- 03/15/2023 -- An investigation was announced for current long-term investors in shares of Twist Bioscience Corporation (NASDAQ:TWST) concerning potential breaches of... 
Via SBWire
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery Using New Methodology on Optofluidic Platform
From Twist Bioscience Corporation
Via Business Wire
TWST FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – TWST
From Rosen Law Firm
Via Business Wire
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Twist Bioscience Corporation (TWST) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
From The Law Offices of Frank R. Cruz
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Iris, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
TWST FINAL DEADLINE FRIDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – TWST
From The Rosen Law Firm PA
Via GlobeNewswire
TWIST BIOSCIENCE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST
From Kahn Swick & Foti, LLC
Via Business Wire
Twist Bioscience Announces Technology Early Access of Enhanced Whole Genome Sequencing Solution at AGBT
From Twist Bioscience Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Corporation (NASDAQ: TWST) Investor Alert: Deadline in Lawsuit on February 10, 2023
San Diego, CA -- (SBWIRE) -- 01/31/2023 -- The Shareholders Foundation announced that a deadline is coming up on February 10, 2023 in the lawsuit filed for certain investors of Twist Bioscience... 
Via SBWire
DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Twist Bioscience Corporation Securities Fraud Class Action Lawsuit
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
TWST FINAL DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.